Significant Ownership of Venrock Healthcare Capital Partners II, L.P.

Signature - Title
/s/ Sherman G. Souther - By VHCP Management II, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Venrock Healthcare Capital Partners II, L.P..

Notify me when Venrock Healthcare Capital Partners II, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Venrock Healthcare Capital Partners II, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
COGT Cogent Biosciences, Inc. Common Stock, $0.001 par value per share 4.2% $44,463,093 -$15,815,581 4,755,411 -26% Venrock Healthcare Capital Partners II, L.P. 30 Jun 2025
TRVI Trevi Therapeutics, Inc. Common Stock, $0.001 par value 1.4% $8,042,002 1,266,457 Venrock Healthcare Capital Partners II, L.P. 31 Dec 2024
DBVT DBV TECHNOLOGIES S.A. Ordinary Shares, nominal value 0.01 euro per share 0% $0 -$213,888,386 0 -100% Venrock Healthcare Capital Partners II, L.P. 31 Dec 2025

Schedules 13D/G Reported by Venrock Healthcare Capital Partners II, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.